Katherine Eade Net Worth & Insider Trades

Katherine Eade - Director, Harvard Bioscience Inc

As of May 26, 2022

What is Katherine Eade's Net Worth?

The current estimated net worth of Harvard Bioscience Inc's Director, Katherine Eade, is estimated to be about $585.79K . Katherine Eade owns about 121,515 units of Harvard Bioscience Inc common stock. In the last 5 years at Harvard Bioscience Inc, Katherine Eade has sold an estimated value of $0 worth.

What is Katherine Eade's Past Insider Trading?

Katherine Eade's largest purchase order was 39,915 units , worth over $98.83K on August 12, 2019. In total, Katherine Eade has made about 15 transactions over 5 years of their time at Harvard Bioscience Inc. Katherine Eade usually trades in January, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Katherine Eade's' Mailing Address?

  • Mailing address is C/o Harvard Bioscience, Inc. 84 October Hill Road #10 Holliston MA 01746 MA

Harvard Bioscience Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
James W. Green 2020 $573,710 $215,304 $573,710 $1,223,771 $33,958 $2,620,453
James W. Green 2019 $264,789 - - $1,972,503 $43,431 $2,280,723
Michael A. Rossi 2020 $340,000 $63,798 $113,333 $241,752 $19,278 $778,161
Michael A. Rossi 2019 $145,157 - $85,000 $88,821 $1,569 $320,547
Kenneth Olson 2020 $285,263 $54,416 $96,667 $206,196 $186,540 $829,082
Kenneth Olson 2019 $53,000 - $50,000 $51,355 $1,966 $156,321
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1123494/000117184321002394/def14a_040521.htm

What are Harvard Bioscience Inc's Past Insider Trades?

Harvard Bioscience Inc's most recent insider trade came on August 29, 2022 by Bertrand Loy who bought 9,291 units worth $31.68K . In the last 18 years, insiders at Harvard Bioscience Inc have sold an estimated value of $45.71M and bought an estimated value of $24.61M worth of shares. Insider trading is most common in May, with the busiest year in 2006. The most active traders at the company are David Green, Director,  James Green, Chief Executive Officer,  and John Kennedy, Director .

HARVARD BIOSCIENCE INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1